Study details
Enrolling now
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Suvankar Majumdar
NCT IDNCT06635902ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
99
Study length
about 4.3 years
Ages
4–21
Locations
1 site in DC
What this study is about
Researchers are testing if intravenous L-citrulline helps treat acute pain episodes in people with sickle cell disease. The trial also aims to learn about the safety of this treatment and how it affects participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take L-citrulline
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug routes
oral (Oral Capsule)
Endpoints
Secondary: Opioid consumption, Pain scores, Safety